THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION

Detalhes bibliográficos
Autor(a) principal: Smalci, Anderson
Data de Publicação: 2020
Outros Autores: da Silva, Orlando Roque
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Metropolitana de Sustentabilidade
Texto Completo: https://revistaseletronicas.fmu.br/index.php/rms/article/view/2116
Resumo: This study aims to analyze whether the Open Innovation model contributes to the good practices of Cleaner Production - concerning the manufacture of medicinal products -, and how they are correlated. The research methodology - of a qualitative nature - has been developed through semi-structured one-on-one interviews done with members of management and professional agencies from the pharmaceutical sector of São Paulo, as well as reports of a national scientific civil society executive and a higher education professor/researcher; having the content analysis, as its method. It can be observed, through the responses to the interview questions, a low correlation between the terms Cleaner Production and Open Innovation. The conclusion is that Brazilian Pharmaceutical Industry Companies are concerned about meeting the requirements of regulatory agencies, having - with greater frequency - this work carried out by the internal Research and Development area, once the manufactured products are simpler and the production process is better controlled.
id FMU-2_96c368fb60405743909f956179995d20
oai_identifier_str oai:ojs.fmu.br:article/2116
network_acronym_str FMU-2
network_name_str Revista Metropolitana de Sustentabilidade
repository_id_str
spelling THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATIONA LAS BUENAS PRÁCTICAS DE PRODUCCIÓN MÁS LIMPIA EM LAS EMPRESAS INDUSTRIALES FARMACÉUTICAS BRASILEÑAS: LAS CONTRIBUCIONES DE LA INNOVACIÓN ABIERTAAS BOAS PRÁTICAS DE PRODUÇÃO MAIS LIMPA NAS EMPRESAS INDUSTRIAIS FARMACÊUTICAS BRASILEIRAS: AS CONTRIBUIÇÕES DA INOVAÇÃO ABERTACleaner ProductionDynamic CapabilitiesOpen InnovationPharmaceutical Industry Companies. Resource-based View.Empresas de la Industria FarmacéuticaCapacitaciones DinámicasInnovación AbiertaProducción Más LimpiaVisión Basada en Recursos.Empresas Industriais FarmacêuticasCapacitações DinâmicasInovação AbertaProdução Mais LimpaVisão Baseada em Recursos.This study aims to analyze whether the Open Innovation model contributes to the good practices of Cleaner Production - concerning the manufacture of medicinal products -, and how they are correlated. The research methodology - of a qualitative nature - has been developed through semi-structured one-on-one interviews done with members of management and professional agencies from the pharmaceutical sector of São Paulo, as well as reports of a national scientific civil society executive and a higher education professor/researcher; having the content analysis, as its method. It can be observed, through the responses to the interview questions, a low correlation between the terms Cleaner Production and Open Innovation. The conclusion is that Brazilian Pharmaceutical Industry Companies are concerned about meeting the requirements of regulatory agencies, having - with greater frequency - this work carried out by the internal Research and Development area, once the manufactured products are simpler and the production process is better controlled. El objetivo de esta investigación es averiguar si el modelo de Innovación Abierta contribuye a las buenas prácticas de producción más limpia en la fabricación de medicamentos, y cómo ellas se correlacionan. La metodologí­a utilizada es la cualitativa, que se desarrolla por medio de entrevistas individuales semiestructuradas, realizadas con integrantes de órganos de representación patronal y profesional del sector farmacéutico del estado de São Paulo, además de los relatos de un ejecutivo de la sociedad civil cientí­fica nacional y una profesora-investigadora universitaria, para los que se utiliza el método de análisis de contenido. Se ha observado, en las respuestas de los entrevistados, la baja correlación entre los términos "producción más limpia" e "Innovación abierta". Así­, se concluye que las empresas de la industria farmacéutica brasileñas se preocupan por atender a las exigencias de los órganos reguladores, lo que ocurre, con mayor frecuencia, por medio del área de Investigación y Desarrollo interna, ya que los productos que se fabrican son relativamente sencillos y sus procesos de producción son bien controlados. O objetivo desta pesquisa é verificar se o modelo de Inovação Aberta contribui para as boas práticas de Produção Mais Limpa na fabricação de medicamentos, e como estão correlacionadas. A metodologia utilizada é de natureza qualitativa, desenvolvida por meio de entrevistas individuais semiestruturadas, realizadas com integrantes de órgãos de representação patronal e profissional do setor farmacêutico de São Paulo, bem como o relato de um executivo da sociedade civil cientí­fica nacional e de uma professora/pesquisadora universitária; sendo, a análise de conteúdo, o método utilizado. Observa-se, nas respostas dos entrevistados, a baixa correlação dos termos Produção Mais Limpa e Inovação Aberta. Assim, conclui-se que as empresas industriais farmacêuticas brasileiras estão preocupadas em atender í s exigências dos órgãos reguladores, o que se dá - com maior frequência - pela área de Pesquisa e Desenvolvimento interna, porque os produtos fabricados são relativamente simples, e seus processos de produção são bem controlados.COMPLEXO EDUCACIONAL FMU2020-02-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionpesquisa qualitativa, por meio de entrevistas individuais e análise de conteúdo.application/pdftext/htmlhttps://revistaseletronicas.fmu.br/index.php/rms/article/view/2116Revista Metropolitana de Sustentabilidade (ISSN 2318-3233); v. 9 n. 3 (2019): (Set./Dez. 2019); 62318-3233reponame:Revista Metropolitana de Sustentabilidadeinstname:Faculdades Metropolitanas Unidas (FMU)instacron:FMUporhttps://revistaseletronicas.fmu.br/index.php/rms/article/view/2116/pdfhttps://revistaseletronicas.fmu.br/index.php/rms/article/view/2116/htmlCopyright (c) 2020 Revista Metropolitana de Sustentabilidade (ISSN 2318-3233)info:eu-repo/semantics/openAccessSmalci, Andersonda Silva, Orlando Roque2021-03-05T18:51:11Zoai:ojs.fmu.br:article/2116Revistahttps://revistaseletronicas.fmu.br/index.php/rms/indexPRIhttps://revistaseletronicas.fmu.br/index.php/rms/oaicelso.sustentabilidade@gmail.com||editor.sustentabilidade@gmail.com|| suporte.revista@gmail.com2318-32332318-3233opendoar:2021-03-05T18:51:11Revista Metropolitana de Sustentabilidade - Faculdades Metropolitanas Unidas (FMU)false
dc.title.none.fl_str_mv THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
A LAS BUENAS PRÁCTICAS DE PRODUCCIÓN MÁS LIMPIA EM LAS EMPRESAS INDUSTRIALES FARMACÉUTICAS BRASILEÑAS: LAS CONTRIBUCIONES DE LA INNOVACIÓN ABIERTA
AS BOAS PRÁTICAS DE PRODUÇÃO MAIS LIMPA NAS EMPRESAS INDUSTRIAIS FARMACÊUTICAS BRASILEIRAS: AS CONTRIBUIÇÕES DA INOVAÇÃO ABERTA
title THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
spellingShingle THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
Smalci, Anderson
Cleaner Production
Dynamic Capabilities
Open Innovation
Pharmaceutical Industry Companies. Resource-based View.
Empresas de la Industria Farmacéutica
Capacitaciones Dinámicas
Innovación Abierta
Producción Más Limpia
Visión Basada en Recursos.
Empresas Industriais Farmacêuticas
Capacitações Dinâmicas
Inovação Aberta
Produção Mais Limpa
Visão Baseada em Recursos.
title_short THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
title_full THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
title_fullStr THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
title_full_unstemmed THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
title_sort THE GOOD PRACTICES OF CLEANER PRODUCTION IN THE BRAZILIAN PHARMACEUTICAL INDUSTRY COMPANIES: THE CONTRIBUTES OF THE OPEN INNOVATION
author Smalci, Anderson
author_facet Smalci, Anderson
da Silva, Orlando Roque
author_role author
author2 da Silva, Orlando Roque
author2_role author
dc.contributor.author.fl_str_mv Smalci, Anderson
da Silva, Orlando Roque
dc.subject.por.fl_str_mv Cleaner Production
Dynamic Capabilities
Open Innovation
Pharmaceutical Industry Companies. Resource-based View.
Empresas de la Industria Farmacéutica
Capacitaciones Dinámicas
Innovación Abierta
Producción Más Limpia
Visión Basada en Recursos.
Empresas Industriais Farmacêuticas
Capacitações Dinâmicas
Inovação Aberta
Produção Mais Limpa
Visão Baseada em Recursos.
topic Cleaner Production
Dynamic Capabilities
Open Innovation
Pharmaceutical Industry Companies. Resource-based View.
Empresas de la Industria Farmacéutica
Capacitaciones Dinámicas
Innovación Abierta
Producción Más Limpia
Visión Basada en Recursos.
Empresas Industriais Farmacêuticas
Capacitações Dinâmicas
Inovação Aberta
Produção Mais Limpa
Visão Baseada em Recursos.
description This study aims to analyze whether the Open Innovation model contributes to the good practices of Cleaner Production - concerning the manufacture of medicinal products -, and how they are correlated. The research methodology - of a qualitative nature - has been developed through semi-structured one-on-one interviews done with members of management and professional agencies from the pharmaceutical sector of São Paulo, as well as reports of a national scientific civil society executive and a higher education professor/researcher; having the content analysis, as its method. It can be observed, through the responses to the interview questions, a low correlation between the terms Cleaner Production and Open Innovation. The conclusion is that Brazilian Pharmaceutical Industry Companies are concerned about meeting the requirements of regulatory agencies, having - with greater frequency - this work carried out by the internal Research and Development area, once the manufactured products are simpler and the production process is better controlled.
publishDate 2020
dc.date.none.fl_str_mv 2020-02-26
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
pesquisa qualitativa, por meio de entrevistas individuais e análise de conteúdo.
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistaseletronicas.fmu.br/index.php/rms/article/view/2116
url https://revistaseletronicas.fmu.br/index.php/rms/article/view/2116
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistaseletronicas.fmu.br/index.php/rms/article/view/2116/pdf
https://revistaseletronicas.fmu.br/index.php/rms/article/view/2116/html
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Metropolitana de Sustentabilidade (ISSN 2318-3233)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Metropolitana de Sustentabilidade (ISSN 2318-3233)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv COMPLEXO EDUCACIONAL FMU
publisher.none.fl_str_mv COMPLEXO EDUCACIONAL FMU
dc.source.none.fl_str_mv Revista Metropolitana de Sustentabilidade (ISSN 2318-3233); v. 9 n. 3 (2019): (Set./Dez. 2019); 6
2318-3233
reponame:Revista Metropolitana de Sustentabilidade
instname:Faculdades Metropolitanas Unidas (FMU)
instacron:FMU
instname_str Faculdades Metropolitanas Unidas (FMU)
instacron_str FMU
institution FMU
reponame_str Revista Metropolitana de Sustentabilidade
collection Revista Metropolitana de Sustentabilidade
repository.name.fl_str_mv Revista Metropolitana de Sustentabilidade - Faculdades Metropolitanas Unidas (FMU)
repository.mail.fl_str_mv celso.sustentabilidade@gmail.com||editor.sustentabilidade@gmail.com|| suporte.revista@gmail.com
_version_ 1798945136325951488

Registros relacionados